Urogen Pharma Ltd (URGN)

CapEx to Revenue

0.08%

Quarterly · Period ending:

URGN logo

URGN CapEx to Revenue

Latest reported0.08%
URGN Quarterly CapEx/Revenue (0.00% → 0.08%)
High-resolution chart · PNG

URGN capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Urogen Pharma Ltd CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
0.0828%
0.106%
0.0449%
0.3166%
0.5823%
0.2172%
0.4681%
0.3809%
0.3845%
0%
0.2276%
0.4796%
0.071%
0.1338%
0.0719%
0.9173%
0.3794%
0.1843%
1.2489%
1.7091%
0.5295%
3.8343%
2.1592%
19.0696%
77.1505%
0%
0%
0%
222.2222%
0%
0%
117.3145%
36.2637%
14.9688%
46.789%
0.256%
0%
410.5263%
0.6674%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.